Literature DB >> 14694052

The prognostic value of cognitive functioning in the survival of patients with high-grade glioma.

M Klein1, T J Postma, M J B Taphoorn, N K Aaronson, W P Vandertop, M Muller, H M van der Ploeg, J J Heimans.   

Abstract

The authors studied cognitive functioning as a potential predictor of survival in 68 newly diagnosed patients with high-grade glioma. In a combined Cox proportional hazards model, the influence of tumor, treatment, and patient characteristics, including cognitive functioning, was studied. Older age and higher tumor grade were associated with poorer survival. Although cognitive impairment was not found to be an independent prognostic factor for the entire sample, it was associated with significantly poorer survival among older patients with World Health Organization grade IV gliomas. Assessment of cognitive functioning in these patients may improve clinical decision making and thus quality of treatment.

Entities:  

Mesh：

Year:  2003        PMID： 14694052     DOI： 10.1212/01.wnl.0000098892.33018.4c

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  37 in total

1.  Health-related quality of life in high-grade glioma patients: a prospective single-center study.

Authors:  Cagdas Yavas; Faruk Zorlu; Gokhan Ozyigit; Murat Gurkaynak; Guler Yavas; Deniz Yuce; Mustafa Cengiz; Ferah Yildiz; Fadil Akyol
Journal:  Support Care Cancer       Date:  2011-12-13       Impact factor: 3.603

2.  Cognitive functioning in newly presenting patients with supratentorial intracranial tumors: is there a role for inspection time?

Authors:  Jennifer L Scotland; Ian R Whittle; Ian J Deary
Journal:  Neuro Oncol       Date:  2012-02-03       Impact factor: 12.300

3.  Synchronized brain activity and neurocognitive function in patients with low-grade glioma: a magnetoencephalography study.

Authors:  Ingeborg Bosma; Linda Douw; Fabrice Bartolomei; Jan J Heimans; Bob W van Dijk; Tjeerd J Postma; Cornelis J Stam; Jaap C Reijneveld; Martin Klein
Journal:  Neuro Oncol       Date:  2008-07-23       Impact factor: 12.300

4.  Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab.

Authors:  Jeffrey S Wefel; Timothy Cloughesy; James L Zazzali; Maoxia Zheng; Michael Prados; Patrick Y Wen; Tom Mikkelsen; David Schiff; Lauren E Abrey; W K Alfred Yung; Nina Paleologos; Martin K Nicholas; Randy Jensen; James Vredenburgh; Asha Das; Henry S Friedman
Journal:  Neuro Oncol       Date:  2011-05-09       Impact factor: 12.300

5.  The association between cognitive functioning and health-related quality of life in low-grade glioma patients.

Authors:  Florien W Boele; Maaike Zant; Emma C E Heine; Neil K Aaronson; Martin J B Taphoorn; Jaap C Reijneveld; Tjeerd J Postma; Jan J Heimans; Martin Klein
Journal:  Neurooncol Pract       Date:  2014-05-06

6.  Cognitive dysfunction in patients with brain metastases: influences on caregiver resilience and coping.

Authors:  Marlon Garzo Saria; Natasia Courchesne; Lorraine Evangelista; Joshua Carter; Daniel A MacManus; Mary Kay Gorman; Adeline M Nyamathi; Linda R Phillips; David Piccioni; Santosh Kesari; Sally Maliski
Journal:  Support Care Cancer       Date:  2016-12-05       Impact factor: 3.603

7.  The course of neurocognitive functioning in high-grade glioma patients.

Authors:  Ingeborg Bosma; Maaike J Vos; Jan J Heimans; Martin J B Taphoorn; Neil K Aaronson; Tjeerd J Postma; Henk M van der Ploeg; Martin Muller; W Peter Vandertop; Ben J Slotman; Martin Klein
Journal:  Neuro Oncol       Date:  2006-10-03       Impact factor: 12.300

8.  Minor cognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care.

Authors:  Xin Gao; Holly G Prigerson; Eli L Diamond; Baohui Zhang; Alexi A Wright; Fremonta Meyer; Paul K Maciejewski
Journal:  J Pain Symptom Manage       Date:  2012-07-28       Impact factor: 3.612

9.  Neurocognitive training in patients with high-grade glioma: a pilot study.

Authors:  Marco Ronald Hassler; Katarzyna Elandt; Matthias Preusser; Johann Lehrner; Petra Binder; Karin Dieckmann; Andrea Rottenfusser; Christine Marosi
Journal:  J Neurooncol       Date:  2009-09-10       Impact factor: 4.130

10.  Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: a magnetoencephalography study.

Authors:  Eelco van Duinkerken; Martin Klein; Niki S M Schoonenboom; Roel P L M Hoogma; Annette C Moll; Frank J Snoek; Cornelis J Stam; Michaela Diamant
Journal:  Diabetes       Date:  2009-07-07       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.